PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance
- PMID: 39547224
- DOI: 10.1016/j.molcel.2024.10.027
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance
Erratum in
-
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance.Mol Cell. 2025 Sep 4;85(17):3343-3344. doi: 10.1016/j.molcel.2025.08.005. Epub 2025 Aug 14. Mol Cell. 2025. PMID: 40816288 No abstract available.
Abstract
Selenocysteine (Sec) metabolism is crucial for cellular function and ferroptosis prevention and begins with the uptake of the Sec carrier, selenoprotein P (SELENOP). Following uptake, Sec released from SELENOP is metabolized via selenocysteine lyase (SCLY), producing selenide, a substrate for selenophosphate synthetase 2 (SEPHS2), which provides the essential selenium donor, selenophosphate (H2SePO3-), for the biosynthesis of the Sec-tRNA. Here, we discovered an alternative pathway in Sec metabolism mediated by peroxiredoxin 6 (PRDX6), independent of SCLY. Mechanistically, we demonstrate that PRDX6 can readily react with selenide and interact with SEPHS2, potentially acting as a selenium delivery system. Moreover, we demonstrate the functional significance of this alternative route in human cancer cells, revealing a notable association between elevated expression of PRDX6 and human MYCN-amplified neuroblastoma subtype. Our study sheds light on a previously unrecognized aspect of Sec metabolism and its implications in ferroptosis, offering further possibilities for therapeutic exploitation.
Keywords: cancer metabolism; cell death; ferroptosis; neuroblastoma; selenium; selenocysteine metabolism.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Update of
-
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance.bioRxiv [Preprint]. 2024 Jun 6:2024.06.04.597364. doi: 10.1101/2024.06.04.597364. bioRxiv. 2024. Update in: Mol Cell. 2024 Dec 5;84(23):4645-4659.e9. doi: 10.1016/j.molcel.2024.10.027. PMID: 38895225 Free PMC article. Updated. Preprint.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous